TWD 32.6
(-1.51%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 52.92 Million | -63.65 Million | 76.43 Million | 104.37 Million | 170.88 Million |
Net Income | 169.74 Million | 12.68 Million | 52.27 Million | -39.83 Million | -12.51 Million |
Depreciation & Amortization | 58.22 Million | 61.45 Million | 65 Million | 60.43 Million | 67.22 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 69.61 Million | -170.11 Million | -48.51 Million | 70.45 Million | 125.09 Million |
Other non-cash items | 42.23 Million | 84.6 Million | 45.53 Million | 41.96 Million | -4.36 Million |
Investing Cash Flow | 133.23 Million | -19.16 Million | -23.68 Million | -34.65 Million | 40.22 Million |
Investments in PPE | -25.45 Million | -8.39 Million | -10.1 Million | -36.14 Million | -21.97 Million |
Acquisitions | -111.9 Million | 23 Thousand | 9.72 Million | 4.74 Million | 38.96 Million |
Investment purchases | -150.27 Million | -25.02 Million | -7.61 Million | -7.24 Million | - |
Sales/Maturities of investments | -30.87 Million | 7.93 Million | - | 1.42 Million | 22.88 Million |
Other Investing Activities | 293.53 Million | 18 Thousand | -8.4 Million | 56 Thousand | 348 Thousand |
Financing Cash Flow | 309.54 Million | 64.02 Million | -38.7 Million | 6.51 Million | -155.24 Million |
Debt repayment | -89.81 Million | -109.19 Million | -19.94 Million | -25.92 Million | -76.22 Million |
Dividends payments | - | - | - | - | -61.5 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 466.8 Million | - | - | - | - |
Other Financing Activities | -771 Thousand | -575 Thousand | -103.9 Million | -53.91 Million | 243.38 Million |
Accounts receivables | 117.86 Million | -1.57 Million | -53.73 Million | -21.05 Million | 78.96 Million |
Accounts payables | -16.45 Million | -131.62 Million | 163.03 Million | 30.09 Million | -86.68 Million |
Inventory | -35.35 Million | -9.27 Million | -198.12 Million | 79.46 Million | 137.61 Million |
Other working capital | -279 Thousand | -25.29 Million | 41.05 Million | -24.41 Million | -4.79 Million |
Cash at beginning of period | 340.27 Million | 304.85 Million | 300.19 Million | 240.64 Million | 204.28 Million |
Cash at end of period | 835.77 Million | 340.27 Million | 304.85 Million | 300.19 Million | 240.64 Million |
Capital Expenditure | -25.45 Million | -8.39 Million | -10.1 Million | -36.14 Million | -21.97 Million |
Effect of forex changes on cash | -206 Thousand | 54.21 Million | -9.4 Million | -16.67 Million | -19.51 Million |
Net cash flow / Change in cash | 495.49 Million | 35.42 Million | 4.65 Million | 59.55 Million | 36.35 Million |
Free Cash Flow | 27.46 Million | -72.04 Million | 66.33 Million | 68.23 Million | 148.91 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -12.99 Million | -2.58 Million | -14.05 Million | 169.74 Million | 172.49 Million | 13.35 Million |
Depreciation & Amortization | 14.77 Million | 15 Million | 15.38 Million | 58.22 Million | 15.25 Million | 14.18 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -144.34 Million | -4.69 Million | -105.51 Million | 69.61 Million | 89.78 Million | 45.45 Million |
Other non-cash items | 54 Million | -3.95 Million | 7.14 Million | 42.23 Million | 28.61 Million | -973 Thousand |
Investing Cash Flow | -114.9 Million | -118.4 Million | -36.41 Million | 133.23 Million | 221.28 Million | -25.09 Million |
Investments in PPE | -13.2 Million | -5.6 Million | 2.06 Million | -25.45 Million | -4.56 Million | -10.92 Million |
Acquisitions | 12 Thousand | -109.1 Million | -39 Million | -111.9 Million | -63 Million | -9.9 Million |
Investment purchases | -101.71 Million | -2.01 Million | 34.2 Million | -150.27 Million | -12.09 Million | -11.59 Million |
Sales/Maturities of investments | - | - | -38.37 Million | -30.87 Million | 3.73 Million | 3.75 Million |
Other Investing Activities | -12.38 Million | -8.12 Million | 2.05 Million | 293.53 Million | 296.44 Million | -772 Thousand |
Financing Cash Flow | 209.53 Million | -98.17 Million | 429.9 Million | 309.54 Million | -118.86 Million | 38.55 Million |
Debt repayment | -220.93 Million | -81.41 Million | -15.68 Million | -89.81 Million | -101.84 Million | -47.63 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 466.8 Million | 466.8 Million | - | - |
Other Financing Activities | -126 Thousand | -69 Thousand | -332 Thousand | -771 Thousand | 60 Thousand | -362 Thousand |
Accounts receivables | -25.97 Million | -7.39 Million | 55.91 Million | 117.86 Million | 40.66 Million | -32.36 Million |
Accounts payables | -14.54 Million | 9.61 Million | -17.29 Million | -16.45 Million | 16.74 Million | 19.93 Million |
Inventory | 29.73 Million | -8.7 Million | -120.99 Million | -35.35 Million | 9.53 Million | 57.35 Million |
Other working capital | -133.55 Million | 5.42 Million | -23.53 Million | -279 Thousand | 30.11 Million | -13.5 Million |
Cash at beginning of period | 641.13 Million | 835.77 Million | 595.02 Million | 340.27 Million | 406.88 Million | 324.41 Million |
Cash at end of period | 617.28 Million | 641.13 Million | 835.77 Million | 835.77 Million | 595.02 Million | 406.88 Million |
Capital Expenditure | -13.2 Million | -5.6 Million | 2.06 Million | -25.45 Million | -4.56 Million | -10.92 Million |
Effect of forex changes on cash | 10.41 Million | 19.42 Million | -18.29 Million | -206 Thousand | 22.39 Million | 375 Thousand |
Net cash flow / Change in cash | -23.84 Million | -194.63 Million | 240.74 Million | 495.49 Million | 188.14 Million | 82.46 Million |
Free Cash Flow | -142.09 Million | -3.08 Million | -132.38 Million | 27.46 Million | 58.77 Million | 57.71 Million |
3325
AIDX
PRECWIRE
UFCS
TRMED
UCOBANK